Immune System Checkpoints

Peter discusses the role of checkpoint inhibitors in regulating the immune system, specifically how CTLA-4 acts as a brake on T cells. He explores the intriguing idea of blocking this checkpoint to enhance immune responses against cancer, contrasting it with previous strategies that aimed to boost T cell activity. The conversation highlights the potential of this approach, especially for patients facing dire prognoses in aggressive cancers like melanoma and kidney cancer.